▶ 調査レポート

短腸症候群(SBS)治療薬の世界市場:市場規模・現状・予測

• 英文タイトル:Global Short Bowel Syndrome (SBS) Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。短腸症候群(SBS)治療薬の世界市場:市場規模・現状・予測 / Global Short Bowel Syndrome (SBS) Drugs Market Size, Status and Forecast 2019-2025 / QYR9ST04542資料のイメージです。• レポートコード:QYR9ST04542
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、短腸症候群(SBS)治療薬の世界市場について調査・分析し、短腸症候群(SBS)治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(グルカゴン様ペプチド-2(GLP-2)、成長ホルモン、グルタミン、その他)、用途別(病院、クリニック、小売薬局)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の短腸症候群(SBS)治療薬市場動向
・主要企業別マーケットシェア
・短腸症候群(SBS)治療薬の種類別市場規模2014-2019
(グルカゴン様ペプチド-2(GLP-2)、成長ホルモン、グルタミン、その他)
・短腸症候群(SBS)治療薬の用途別市場規模2014-2019
(病院、クリニック、小売薬局)
・短腸症候群(SBS)治療薬の北米市場:主要企業・種類別/用途別市場規模
・短腸症候群(SBS)治療薬のヨーロッパ市場:主要企業・種類別/用途別市場規模
・短腸症候群(SBS)治療薬の中国市場:主要企業・種類別/用途別市場規模
・短腸症候群(SBS)治療薬の日本国内市場:主要企業・種類別/用途別市場規模
・短腸症候群(SBS)治療薬の東南アジア市場:主要企業・種類別/用途別市場規模
・短腸症候群(SBS)治療薬のインド市場:主要企業・種類別/用途別市場規模
・短腸症候群(SBS)治療薬の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Merck、Shire、Emmaus Medical、Ardelyx、Naia Pharmaceuticals、Nutrinia、OxThera、Sancilio Pharmaceuticals、Zealand Pharma)
・短腸症候群(SBS)治療薬の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.
In 2018, the global Short Bowel Syndrome (SBS) Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Short Bowel Syndrome (SBS) Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Short Bowel Syndrome (SBS) Drugs development in United States, Europe and China.

The key players covered in this study
Merck
Shire
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Market segment by Type, the product can be split into
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other

Market segment by Application, split into
Hospitals
Clinics
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Short Bowel Syndrome (SBS) Drugs status, future forecast, growth opportunity, key market and key players.
To present the Short Bowel Syndrome (SBS) Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Short Bowel Syndrome (SBS) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Glucagon-Like Peptide-2 (GLP-2)
1.4.3 Growth Hormone
1.4.4 Glutamine
1.4.5 Other
1.5 Market by Application
1.5.1 Global Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Short Bowel Syndrome (SBS) Drugs Market Size
2.2 Short Bowel Syndrome (SBS) Drugs Growth Trends by Regions
2.2.1 Short Bowel Syndrome (SBS) Drugs Market Size by Regions (2014-2025)
2.2.2 Short Bowel Syndrome (SBS) Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Short Bowel Syndrome (SBS) Drugs Market Size by Manufacturers
3.1.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Short Bowel Syndrome (SBS) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Short Bowel Syndrome (SBS) Drugs Key Players Head office and Area Served
3.3 Key Players Short Bowel Syndrome (SBS) Drugs Product/Solution/Service
3.4 Date of Enter into Short Bowel Syndrome (SBS) Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019)
4.2 Global Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
5.2 Short Bowel Syndrome (SBS) Drugs Key Players in United States
5.3 United States Short Bowel Syndrome (SBS) Drugs Market Size by Type
5.4 United States Short Bowel Syndrome (SBS) Drugs Market Size by Application

6 Europe
6.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
6.2 Short Bowel Syndrome (SBS) Drugs Key Players in Europe
6.3 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Type
6.4 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Application

7 China
7.1 China Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
7.2 Short Bowel Syndrome (SBS) Drugs Key Players in China
7.3 China Short Bowel Syndrome (SBS) Drugs Market Size by Type
7.4 China Short Bowel Syndrome (SBS) Drugs Market Size by Application

8 Japan
8.1 Japan Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
8.2 Short Bowel Syndrome (SBS) Drugs Key Players in Japan
8.3 Japan Short Bowel Syndrome (SBS) Drugs Market Size by Type
8.4 Japan Short Bowel Syndrome (SBS) Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
9.2 Short Bowel Syndrome (SBS) Drugs Key Players in Southeast Asia
9.3 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size by Type
9.4 Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size by Application

10 India
10.1 India Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
10.2 Short Bowel Syndrome (SBS) Drugs Key Players in India
10.3 India Short Bowel Syndrome (SBS) Drugs Market Size by Type
10.4 India Short Bowel Syndrome (SBS) Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Short Bowel Syndrome (SBS) Drugs Market Size (2014-2019)
11.2 Short Bowel Syndrome (SBS) Drugs Key Players in Central & South America
11.3 Central & South America Short Bowel Syndrome (SBS) Drugs Market Size by Type
11.4 Central & South America Short Bowel Syndrome (SBS) Drugs Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.1.4 Merck Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Shire
12.2.1 Shire Company Details
12.2.2 Company Description and Business Overview
12.2.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.2.4 Shire Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.2.5 Shire Recent Development
12.3 Emmaus Medical
12.3.1 Emmaus Medical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.3.4 Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.3.5 Emmaus Medical Recent Development
12.4 Ardelyx
12.4.1 Ardelyx Company Details
12.4.2 Company Description and Business Overview
12.4.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.4.4 Ardelyx Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.4.5 Ardelyx Recent Development
12.5 Naia Pharmaceuticals
12.5.1 Naia Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.5.5 Naia Pharmaceuticals Recent Development
12.6 Nutrinia
12.6.1 Nutrinia Company Details
12.6.2 Company Description and Business Overview
12.6.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.6.4 Nutrinia Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.6.5 Nutrinia Recent Development
12.7 OxThera
12.7.1 OxThera Company Details
12.7.2 Company Description and Business Overview
12.7.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.7.4 OxThera Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.7.5 OxThera Recent Development
12.8 Sancilio Pharmaceuticals
12.8.1 Sancilio Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.8.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.8.5 Sancilio Pharmaceuticals Recent Development
12.9 Zealand Pharma
12.9.1 Zealand Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Short Bowel Syndrome (SBS) Drugs Introduction
12.9.4 Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
12.9.5 Zealand Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Short Bowel Syndrome (SBS) Drugs Key Market Segments
Table Key Players Short Bowel Syndrome (SBS) Drugs Covered
Table Global Short Bowel Syndrome (SBS) Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size Market Share by Type 2014-2025
Figure Glucagon-Like Peptide-2 (GLP-2) Figures
Table Key Players of Glucagon-Like Peptide-2 (GLP-2)
Figure Growth Hormone Figures
Table Key Players of Growth Hormone
Figure Glutamine Figures
Table Key Players of Glutamine
Figure Other Figures
Table Key Players of Other
Table Global Short Bowel Syndrome (SBS) Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Retail Pharmacies Case Studies
Figure Short Bowel Syndrome (SBS) Drugs Report Years Considered
Table Global Short Bowel Syndrome (SBS) Drugs Market Size 2014-2025 (Million US$)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Short Bowel Syndrome (SBS) Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Short Bowel Syndrome (SBS) Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Short Bowel Syndrome (SBS) Drugs Market Share by Regions 2014-2019
Figure Global Short Bowel Syndrome (SBS) Drugs Market Share by Regions 2014-2019
Figure Global Short Bowel Syndrome (SBS) Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Short Bowel Syndrome (SBS) Drugs Market Share by Manufacturers (2014-2019)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Share by Manufacturers in 2018
Table Global Short Bowel Syndrome (SBS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Short Bowel Syndrome (SBS) Drugs Product/Solution/Service
Table Date of Enter into Short Bowel Syndrome (SBS) Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Short Bowel Syndrome (SBS) Drugs Market Size Share by Type (2014-2019)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size Market Share by Type (2014-2019)
Table Global Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Short Bowel Syndrome (SBS) Drugs Market Size Share by Application (2014-2019)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size Market Share by Application (2014-2019)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application in 2018
Figure United States Short Bowel Syndrome (SBS) Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Short Bowel Syndrome (SBS) Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Short Bowel Syndrome (SBS) Drugs Market Share (2018-2019)
Table United States Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Short Bowel Syndrome (SBS) Drugs Market Share by Type (2014-2019)
Table United States Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2019)
Figure Europe Short Bowel Syndrome (SBS) Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Short Bowel Syndrome (SBS) Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Short Bowel Syndrome (SBS) Drugs Market Share (2018-2019)
Table Europe Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Short Bowel Syndrome (SBS) Drugs Market Share by Type (2014-2019)
Table Europe Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2019)
Figure China Short Bowel Syndrome (SBS) Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Short Bowel Syndrome (SBS) Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Short Bowel Syndrome (SBS) Drugs Market Share (2018-2019)
Table China Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-20189) (Million US$)
Table China Short Bowel Syndrome (SBS) Drugs Market Share by Type (2014-2019)
Table China Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019) (Million US$)
Table China Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2019)
Figure Japan Short Bowel Syndrome (SBS) Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Short Bowel Syndrome (SBS) Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Short Bowel Syndrome (SBS) Drugs Market Share (2018-2019)
Table Japan Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Short Bowel Syndrome (SBS) Drugs Market Share by Type (2014-2019)
Table Japan Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Short Bowel Syndrome (SBS) Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Short Bowel Syndrome (SBS) Drugs Market Share (2018-2019)
Table Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Share by Type (2014-2019)
Table Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2019)
Figure India Short Bowel Syndrome (SBS) Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Short Bowel Syndrome (SBS) Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Short Bowel Syndrome (SBS) Drugs Market Share (2018-2019)
Table India Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019) (Million US$)
Table India Short Bowel Syndrome (SBS) Drugs Market Share by Type (2014-2019)
Table India Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019) (Million US$)
Table India Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2019)
Figure Central & South America Short Bowel Syndrome (SBS) Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Short Bowel Syndrome (SBS) Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Short Bowel Syndrome (SBS) Drugs Market Share (2018-2019)
Table Central & South America Short Bowel Syndrome (SBS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Short Bowel Syndrome (SBS) Drugs Market Share by Type (2014-2019)
Table Central & South America Short Bowel Syndrome (SBS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Short Bowel Syndrome (SBS) Drugs Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table Merck Recent Development
Table Shire Company Details
Table Shire Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table Shire Recent Development
Table Emmaus Medical Company Details
Table Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)(Million US$)
Figure Emmaus Medical Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table Emmaus Medical Recent Development
Table Ardelyx Company Details
Table Ardelyx Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)(Million US$)
Figure Ardelyx Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table Ardelyx Recent Development
Table Naia Pharmaceuticals Company Details
Table Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)(Million US$)
Figure Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table Naia Pharmaceuticals Recent Development
Table Nutrinia Company Details
Table Nutrinia Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)(Million US$)
Figure Nutrinia Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table Nutrinia Recent Development
Table OxThera Company Details
Table OxThera Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)(Million US$)
Figure OxThera Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table OxThera Recent Development
Table Sancilio Pharmaceuticals Company Details
Table Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)(Million US$)
Figure Sancilio Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table Sancilio Pharmaceuticals Recent Development
Table Zealand Pharma Company Details
Table Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)(Million US$)
Figure Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome (SBS) Drugs Business (2014-2019)
Table Zealand Pharma Recent Development
Table Global Short Bowel Syndrome (SBS) Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size Share by Regions (2019-2025)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size Share by Regions in 2025
Figure United States Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Short Bowel Syndrome (SBS) Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size by Product (2019-2025)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size by Product in 2025
Table Global Short Bowel Syndrome (SBS) Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size by Application (2019-2025)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources